You're using a free limited version of DrugPatentWatch: Upgrade for Complete Access

Last Updated: January 14, 2025

Mylan Pharms Inc Company Profile


✉ Email this page to a colleague

« Back to Dashboard


What is the competitive landscape for MYLAN PHARMS INC, and what generic and branded alternatives to MYLAN PHARMS INC drugs are available?

MYLAN PHARMS INC has forty-two approved drugs.

There are eighteen tentative approvals on MYLAN PHARMS INC drugs.

Summary for Mylan Pharms Inc
US Patents:0
Tradenames:39
Ingredients:39
NDAs:42

Drugs and US Patents for Mylan Pharms Inc

Applicant Tradename Generic Name Dosage NDA Approval Date TE Type RLD RS Patent No. Patent Expiration Product Substance Delist Req. Exclusivity Expiration
Mylan Pharms Inc RIZATRIPTAN BENZOATE rizatriptan benzoate TABLET;ORAL 201993-001 Dec 31, 2012 AB RX No No ⤷  Subscribe ⤷  Subscribe
Mylan Pharms Inc ATORVASTATIN CALCIUM atorvastatin calcium TABLET;ORAL 091226-003 May 29, 2012 AB RX No No ⤷  Subscribe ⤷  Subscribe
Mylan Pharms Inc FAMOTIDINE famotidine TABLET;ORAL 075457-001 Apr 18, 2001 DISCN No No ⤷  Subscribe ⤷  Subscribe
Mylan Pharms Inc PINDOLOL pindolol TABLET;ORAL 074018-001 Sep 24, 1992 DISCN No No ⤷  Subscribe ⤷  Subscribe
>Applicant >Tradename >Generic Name >Dosage >NDA >Approval Date >TE >Type >RLD >RS >Patent No. >Patent Expiration >Product >Substance >Delist Req. >Exclusivity Expiration
Similar Applicant Names
Applicants may be listed under multiple names.
Here is a list of applicants with similar names.

Make Better Decisions: Try a trial or see plans & pricing

Drugs may be covered by multiple patents or regulatory protections. All trademarks and applicant names are the property of their respective owners or licensors. Although great care is taken in the proper and correct provision of this service, thinkBiotech LLC does not accept any responsibility for possible consequences of errors or omissions in the provided data. The data presented herein is for information purposes only. There is no warranty that the data contained herein is error free. thinkBiotech performs no independent verification of facts as provided by public sources nor are attempts made to provide legal or investing advice. Any reliance on data provided herein is done solely at the discretion of the user. Users of this service are advised to seek professional advice and independent confirmation before considering acting on any of the provided information. thinkBiotech LLC reserves the right to amend, extend or withdraw any part or all of the offered service without notice.